Anifrolumab is a type I interferon (IFN) receptor antagonist, a human monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research.
Purity:
>99.0%
CAS Number:
[1326232-46-5]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted